Publikationen, an denen er mitarbeitet Benito Almirante Grajera (24)

2021

  1. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  2. Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis

    Clinical Microbiology and Infection

2019

  1. Recommendations from a panel of experts on the usefulness of fidaxomicin for the treatment of infections caused by Clostridium difficile

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 1, pp. 50-59

  2. Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles

    Microbial Pathogenesis, Vol. 128, pp. 112-118

2017

  1. High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2102-2109

2016

  1. Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly

    Journal of Infection, Vol. 72, Núm. 3, pp. 309-316

2014

  1. Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin

    Journal of Antimicrobial Chemotherapy

  2. Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals

    Clinical Microbiology and Infection, Vol. 20, Núm. 4, pp. 361-367

2013

  1. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis

    Clinical Infectious Diseases, Vol. 56, Núm. 9, pp. 1261-1268

2011

  1. Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis

    Heart, Vol. 97, Núm. 14, pp. 1138-1142

2008

  1. Rationale, design, and methods for the early surgery in infective endocarditis study (ENDOVAL 1): A multicenter, prospective, randomized trial comparing the state-of-the-art therapeutic strategy versus early surgery strategy in infective endocarditis

    American Heart Journal, Vol. 156, Núm. 3, pp. 431-436

2006

  1. Periannular Complications in Infective Endocarditis Involving Native Aortic Valves

    American Journal of Cardiology, Vol. 98, Núm. 9, pp. 1254-1260

  2. Periannular Complications in Infective Endocarditis Involving Prosthetic Aortic Valves

    American Journal of Cardiology, Vol. 98, Núm. 9, pp. 1261-1268

2005

  1. Aorto-cavitary fistulous tract formation in infective endocarditis: Clinical and echocardiographic features of 76 cases and risk factors for mortality

    European Heart Journal, Vol. 26, Núm. 3, pp. 288-297

  2. Catéteres venosos centrales

    Nefrologia, Vol. 25, Núm. SUPPL.1, pp. 64-92

  3. Creación del acceso vascular

    Nefrologia, Vol. 25, Núm. SUPPL.1, pp. 16-28

  4. Cuidados del acceso vascular

    Nefrologia, Vol. 25, Núm. SUPPL.1, pp. 29-33

  5. Guía de acceso vascular en hemodiálisis

    Angiologia, Vol. 57, Núm. 2, pp. 119-207

  6. Guías de acceso vascular en hemodiálisis

    Nefrologia

  7. Introducción

    Nefrologia